• Home
• About
• Login
• Register
• Search
• Current
• Archives
• Announcements
• Books For Review
• Manuscript Submission
• Editorial Review Board
• Permissions and Licensing
• Advertising Information
• Library Referral Form
• Reprints
• Register
• Subscription Information
• Seven Sins of Opioid Prescription
• Privacy
• Special Issue on Buprenophine
• User License Agreement
• BUPE2021

Open Access  Subscription or Fee Access

Table of Contents

Letters to the Editor

Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients Maurizio Coppola, MD, Raffaella Mondola, MD

PDF 165-166

Articles

The impact of an innovative pharmacist-led inpatient opioid de-escalation intervention in post-operative orthopedic patients Thuy Bui, BPharm, Richard Grygiel, MPharm, Alex Konstantatos, MB BS (Hons), FANZCA, Dip Obs, MRCA, Nick Christelis, Susan Liew, MB BS (Hons), FRACS, Ria Hopkins, BHSci (Hons), MPH, Michael Dooley, BPharm, Grad DipHospPharm, PhD

PDF 167-176

Factors associated with participation and nonparticipation in a VA Whole Health Primary Care Pain Education and Opioid Monitoring Program (PC-POP) Amber Martinson, PhD, Amanda Kutz, PhD, William Marchand, MD, Julie Carney, RN, Jamie Clinton-Lont, MS, CNP

PDF 179-188

Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome Rafia Q. Baloch, MD, Jamie M. Pinto, MD, Patricia Greenberg, MS, Yen-Hong Kuo, PhD, Anita Siu, PharmD, BCPPS

PDF 189-196

National gender differences in the prescribing of opioid medications from 2006 to 2015 Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD

PDF 197-208

An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects Ronald B. Moss, MD, Fiona Carleton, PhD, Charles P. Lollo, PhD, Dennis J. Carlo, PhD

PDF 209-214

Clinical Report

Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review Jonathan P. Eskander, MD, MBA, Junaid Spall, BS, Awais Spall, BA, Rinoo V. Shah, MD, MBA, Alan D. Kaye, MD, PhD

PDF 215-218

Managing breakthrough pain for advanced malignancy in elderly patients: A real challenge Deepti Ahuja, MD, Nandan Choudhary, MD, Vinod Kumar, MD, Nishkarsh Gupta, MD, Sachidanand Jee Bharati, DM

PDF 219-222

Brief Communication

Incidence and correlates of opioid-related psychiatric emergency care: A retrospective, multiyear cohort study Anees Bahji, MD

PDF 223-226

Patient and pediatric caregiver experiences and expectations about opioid risk education and counselling Tanvee Thakur, BPharm, MS, Betty Chewning, PhD

PDF 227-232

Full Issue

Volume 16, Number 3

PDF 161-232